Interferon therapy for malignant brain tumors-present and future
Nagai, M.; Arai, T.
No Shinkei Geka. Neurological Surgery 10(5): 463-476
1982
ISSN/ISBN: 0301-2603 PMID: 6180343 Document Number: 195046
Document emailed within 1 workday
Related Documents
Hirose, Y. 2016: Chemotherapy for brain tumors -Present and future- Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 7): 31-36Takano, S.; Matsumura, A. 2006: Anti-angiogenesis treatment for brain tumors: present and future No Shinkei Geka. Neurological Surgery 34(7): 657-678
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Nakahara, N.; Yoshida, J. 2005: Gene therapy for brain tumors--present conditions and prospects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 458-462
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369
Kochi, M.; Ushio, Y. 1994: Targeting therapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 738-742
Hirschberg, H.; Sørensen, D.R.; Angell-Petersen, E.; Peng, Q.; Tromberg, B.; Sun, C-Ho.; Spetalen, S.; Madsen, S. 2006: Repetitive photodynamic therapy of malignant brain tumors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 261-279
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Bunyaratavej, K.; Siwanuwatn, R.; Chantra, K.; Khaoroptham, S. 2010: Duration of symptoms in brain tumors: influencing factors and its value in predicting malignant tumors Journal of the Medical Association of Thailand 93(8): 903-910
Banzet, P. 1975: Malignant skin melanomas. Present situation and future perspectives La Revue du Praticien 25(51): 4069-4070
Von Gumppenberg, S.; Fink, U.; Lindner, H. 1978: Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors Fortschritte der Medizin 96(31): 1542-1549
Wilander, E.; Bengtsson, A.; Norheim, I.; Oberg, K. 1986: Interferon-induced nuclear DNA alterations in malignant carcinoid tumors in vivo Journal of the National Cancer Institute 76(3): 429-433
Wolf, J.E. 2005: Present and future rosacea therapy Cutis 75(3 Suppl): 4-7; Discussion: 33-36
Eugui, E.M. 2000: Present and future of immunosuppressive therapy Medicina 60(1): 67-80
Peters, B.S.; Conway, K. 2011: Therapy for HIV: past, present, and future Advances in Dental Research 23(1): 23-27
Oberg, K.; Norheim, I.; Lind, E.; Alm, G.; Lundqvist, G.; Wide, L.; Jonsdottir, B.; Magnusson, A.; Wilander, E. 1986: Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results Cancer Treatment Reports 70(11): 1297-1304
Barbeau, A. 1970: L-DOPA therapy past, present and future Arizona Medicine 27(7): 1-4
Motohashi, N. 2004: Electroconvulsive therapy: past, present, and future Seishin Shinkeigaku Zasshi 106(5): 537-545